Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SteriLance Medical is a private medical device manufacturer focused on capillary blood collection, diabetes care, and selected surgical instruments. Founded in 1993 in Suzhou, China, the company develops, manufactures, and sells products including safety lancets, lancing devices, pen needles, heel incision lancets, alcohol pads, and disposable scalpels. Its business appears primarily commercial rather than therapeutic drug development, with products positioned for everyday diabetes self-care, point-of-care sampling, and newborn screening workflows. SteriLance also markets itself as an end-to-end OEM/ODM and product-development partner for global medical device customers. The company maintains operations in China and the United States and emphasizes regulatory certifications, IP, and large-scale manufacturing experience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SteriLance Medical.